State of the Union: CAR T Cell Therapy - a podcast by ReachMD

CME credits: 0.25

Valid until: 31-03-2023

Claim your CME credit at https://reachmd.com/programs/cme/state-of-the-union-car-t-cell-therapy/13658/

Patients with multiple myeloma (MM) whose disease has relapsed multiple times have historically poor outcomes. CAR T cell therapy is a novel therapeutic option for those patients and can provide prolonged responses and improved outcomes. However, the treatment is complex, and careful planning is needed to effectively incorporate these treatments into practice. Drs. Thomas Martin and Larry Anderson discuss CAR T cell therapies for MM with a focus on patient selection, accessibility of treatment, and management of patients after administration.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD